Background
==========

The reporting requirements of various US governmental agencies such as Center for Disease Control (CDC), Agency for Health Care Quality (AHRQ) and US Department of Health and Human Services Center for Medicare Services (CMS) have created huge public datasets that, we believe, are not utilized to their full potential. For example, CDC <http://www.cdc.gov> makes available National Health and Nutrition Examination Survey (NHANES) data. Using NHANES data, Yu et al. \[[@B1]\] predicts diabetes risk using an SVM classifier. CMS <http://www.cms.gov> uses the Medicare and Medicaid claims to create the minimum dataset (MDS). Herbert et al. \[[@B2]\] uses MDS data to identify people with diabetes. In this paper we use the National Inpatient Sample (NIS) data created by AHRQ <http://www.ahrq.gov> Healthcare Utilization Project (HCUP), to predict the risk for eight chronic diseases.

Disease prediction can be applied to different domains such as risk management, tailored health communication and decision support systems. Risk management plays an important role in health insurance companies, mainly in the underwriting process \[[@B3]\]. Health insurers use a process called underwriting in order to classify the applicant as standard or substandard, based on which they compute the policy rate and the premiums individuals have to pay. Currently, in order to classify the applicants, insurers require every applicant to complete a questionnaire, report current medical status and sometimes medical records, or clinical laboratory results, such as blood test, etc. By incorporating machine learning techniques, insurers can make evidence based decisions and can optimize, validate and refine the rules that govern their business. For instance, Yi et al. \[[@B4]\], applied association rules and SVM on an insurance company database to classify the applicants as standard, substandard or declined.

Another domain where disease prediction can be applied is tailored health communication. For example, one can target tailored educational materials and news to a subgroup, within the general population, that has specific disease risks. Cohen et al. \[[@B5]\], discussed how tailored health communication can motivate cancer prevention and early detection. Disease risk prediction along with tailored health communication can lead to an effective channel for delivering disease specific information for people who will be likely to need it.

In addition to population level clinical knowledge, deidentified public datasets represent an important resource for the clinical data mining researchers. While full featured clinical records are hard to access due to privacy issues, deidentified large national public dataset are readily available \[[@B6]\]. Although these public datasets don\'t have all the variables of the original medical records, they still maintain some of their main characteristics such as data imbalance and the use of controlled terminologies (ICD-9 codes).

Several machine learning techniques were applied to healthcare data sets for the prediction of future health care utilization such as predicting individual expenditures and disease risks for patients. Moturu et al. \[[@B7]\], predicted future high-cost patients based on data from Arizona Medicaid program. They created 20 non-random data samples, each sample with 1,000 data points to overcome the problem of imbalanced data. A combination of undersampling and oversampling was employed to a balanced sample. They used a variety of classification methods such as SVM, Logistic Regression, Logistic Model Trees, AdaBoost and LogitBoost. Davis et al. \[[@B8]\], used clustering and collaborative filtering to predict individual disease risks based on medical history. The prediction was performed multiple times for each patient, each time employing different sets of variables. In the end, the clusterings were combined to form an ensemble. The final output was a ranked list of possible diseases for a given patient. Mantzaris et al. \[[@B9]\], predicted Osteoporosis using Artificial Neural Network (ANN). They used two different ANN techniques: Multi-Layer Perceptron (MLP) and Probabilistic Neural Network (PNN). Hebert et al. \[[@B2]\], identified persons with diabetes using Medicare claims data. They ran into a problem where the diabetes claims occur too infrequently to be sensitive indicators for persons with diabetes. In order to increase the sensitivity, physician claims where included. Yu et al. \[[@B1]\], illustrates a method using SVM for detecting persons with diabetes and pre-diabetes.

Zhang et al. \[[@B10]\], conducted a comparative study of ensemble learning approaches. They compared AdaBoost, LogitBoost and RF to logistic regression and SVM in the classification of breast cancer metastasis. They concluded that ensemble learners have higher accuracy compared to the non-ensemble learners.

Together with methods for predicting disease risks, in this paper we discuss a method for dealing with highly imbalanced data. We mentioned two examples \[[@B2],[@B7]\] where the authors encountered class imbalanced problems. Class imbalance occurs if one class contains significantly more samples than the other class. Since the classification process assumes that the data is drawn from the same distribution as the training data, presenting imbalanced data to the classifier will produce undesirable results. The data set we use in this paper is highly imbalanced. For example, only 3.59% of the patients have heart disease, thus it is possible to train a classifier with this data and achieve an accuracy of 96.41% while having 0% sensitivity.

Methods
=======

Dataset
-------

The Nationwide Inpatient Sample (NIS) is a database of hospital inpatient admissions that dates back to 1988 and is used to identify, track, and analyze national trends in health care utilization, access, charges, quality, and outcomes. The NIS database is developed by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the Agency for Healthcare Research and Quality (AHRQ) \[[@B6]\]. This database is publicly available and does not contain any patient identifiers. The NIS data contains discharge level information on all inpatients from a 20% stratified sample of hospitals across the United States, representing approximately 90% of all hospitals in the country \[[@B6]\]. The five strata for hospitals are based on the American Hospital Association classification. HCUP data from the year 2005 will be used in this paper.

The data set contains about 8 million records of hospital stays, with 126 clinical and nonclinical data elements for each visit (table [1](#T1){ref-type="table"}). Nonclinical elements include patient demographics, hospital identification, admission date, zip code, calendar year, total charges and length of stay. Clinical elements include procedures, procedure categories, diagnosis codes and diagnosis categories. Every record contains a vector of 15 diagnosis codes. The diagnosis codes are represented using the *International Classification of Diseases, Ninth Revision, Clinical Modification*(ICD-9-CM). The International Statistical Classification of Disease is designed and published by the World Health Organization (WHO). The ICD-9 codes are alphanumeric codes, 3-5 characters long and used by hospitals, insurance companies and other facilities to describe health conditions of the patient. Every code represents a disease, condition, symptom, or cause of death. There are numerous codes, over 14,000 ICD-9 codes and 3,900 procedures codes.

###### 

HCUP data elements

             Element Name   Element Description
  ---------- -------------- ----------------------------------------------------------
  **1**      AGE            Age in years at admission
  **2**      AGEDAY         Age in days (when age \> 1 year)
  **3**      AMONTH         Admission month
  **4**      ASOURCE        Admission source (uniform)
  **5**      ASOURCEUB92    Admission source (UB-92 standard coding)
  **6**      ASOURCE_X      Admission source (as received from source)
  **7**      ATYPE          Admission type
  **8**      AWEEKEND       Admission day is a weekend
  **9**      DIED           Died during hospitalization
  **10**     DISCWT         Weight to discharges in AHA universe
  **11**     DISPUB92       Disposition of patient (UB-92 standard coding)
  **12**     DISPUNIFORM    Disposition of patient (uniform)
  **13**     DQTR           Discharge quarter
  **14**     DRG            DRG in effect on discharge date
  **15**     DRG18          DRG, version 18
  **16**     DRGVER         DRG grouper version used on discharge date
  **17**     DSHOSPID       Data source hospital identifier
  **18**     DX1            Principal diagnosis
  **19**     DX2            Diagnosis 2
  **20**     DX3            Diagnosis 3
  **21**     DX4            Diagnosis 4
  **22**     DX5            Diagnosis 5
  **23**     DX6            Diagnosis 6
  **24**     DX7            Diagnosis 7
  **25**     DX8            Diagnosis 8
  **26**     DX9            Diagnosis 9
  **27**     DX10           Diagnosis 10
  **28**     DX11           Diagnosis 11
  **29**     DX12           Diagnosis 12
  **30**     DX13           Diagnosis 13
  **31**     DX14           Diagnosis 14
  **32**     DX15           Diagnosis 15
  **\*33**   DXCCS1         CCS: principal diagnosis
  **\*34**   DXCCS2         CCS: diagnosis 2
  **\*35**   DXCCS3         CCS: diagnosis 3
  **\*36**   DXCCS4         CCS: diagnosis 4
  **\*37**   DXCCS5         CCS: diagnosis 5
  **\*38**   DXCCS6         CCS: diagnosis 6
  **\*39**   DXCCS7         CCS: diagnosis 7
  **\*40**   DXCCS8         CCS: diagnosis 8
  **\*41**   DXCCS9         CCS: diagnosis 9
  **\*42**   DXCCS10        CCS: diagnosis 10
  **\*43**   DXCCS11        CCS: diagnosis 11
  **\*44**   DXCCS12        CCS: diagnosis 12
  **\*45**   DXCCS13        CCS: diagnosis 13
  **\*46**   DXCCS14        CCS: diagnosis 14
  **\*47**   DXCCS15        CCS: diagnosis 15
  **48**     ECODE1         E code 1
  **49**     ECODE2         E code 2
  **50**     ECODE3         E code 3
  **51**     ECODE4         E code 4
  **52**     ELECTIVE       Elective versus non-elective admission
  **53**     E_CCS1         CCS: E Code 1
  **54**     E_CCS2         CCS: E Code 2
  **55**     E_CCS3         CCS: E Code 3
  **56**     E_CCS4         CCS: E Code 4
  **57**     FEMALE         Indicator of sex
  **58**     HOSPID         HCUP hospital identification number
  **59**     HOSPST         Hospital state postal code
  **60**     KEY            HCUP record identifier
  **61**     LOS            Length of stay (cleaned)
  **62**     LOS_X          Length of stay (as received from source)
  **63**     MDC            MDC in effect on discharge date
  **64**     MDC18          MDC, version 18
  **65**     MDNUM1_R       Physician 1 number (re-identified)
  **66**     MDNUM2_R       Physician 2 number (re-identified)
  **67**     NDX            Number of diagnoses on this record
  **68**     NECODE         Number of E codes on this record
  **69**     NEOMAT         Neonatal and/or maternal DX and/or PR
  **70**     NIS_STRATUM    Stratum used to sample hospital
  **71**     NPR            Number of procedures on this record
  **72**     PAY1           Primary expected payer (uniform)
  **73**     PAY1_X         Primary expected payer (as received from source)
  **74**     PAY2           Secondary expected payer (uniform)
  **75**     PAY2_X         Secondary expected payer (as received from source)
  **76**     PL_UR_CAT4     Patient Location: Urban-Rural 4 Categories
  **77**     PR1            Principal procedure
  **78**     PR2            Procedure 2
  **79**     PR3            Procedure 3
  **80**     PR4            Procedure 4
  **81**     PR5            Procedure 5
  **82**     PR6            Procedure 6
  **83**     PR7            Procedure 7
  **84**     PR8            Procedure 8
  **85**     PR9            Procedure 9
  **86**     PR10           Procedure 10
  **87**     PR11           Procedure 11
  **88**     PR12           Procedure 12
  **89**     PR13           Procedure 13
  **90**     PR14           Procedure 14
  **91**     PR15           Procedure 15
  **92**     PRCCS1         CCS: principal procedure
  **93**     PRCCS2         CCS: procedure 2
  **94**     PRCCS3         CCS: procedure 3
  **95**     PRCCS4         CCS: procedure 4
  **96**     PRCCS5         CCS: procedure 5
  **97**     PRCCS6         CCS: procedure 6
  **98**     PRCCS7         CCS: procedure 7
  **99**     PRCCS8         CCS: procedure 8
  **100**    PRCCS9         CCS: procedure 9
  **101**    PRCCS10        CCS: procedure 10
  **102**    PRCCS11        CCS: procedure 11
  **103**    PRCCS12        CCS: procedure 12
  **104**    PRCCS13        CCS: procedure 13
  **105**    PRCCS14        CCS: procedure 14
  **106**    PRCCS15        CCS: procedure 15
  **107**    PRDAY1         Number of days from admission to PR1
  **108**    PRDAY2         Number of days from admission to PR2
  **109**    PRDAY3         Number of days from admission to PR3
  **110**    PRDAY4         Number of days from admission to PR4
  **111**    PRDAY5         Number of days from admission to PR5
  **112**    PRDAY6         Number of days from admission to PR6
  **113**    PRDAY7         Number of days from admission to PR7
  **114**    PRDAY8         Number of days from admission to PR8
  **115**    PRDAY9         Number of days from admission to PR9
  **116**    PRDAY10        Number of days from admission to PR10
  **117**    PRDAY11        Number of days from admission to PR11
  **118**    PRDAY12        Number of days from admission to PR12
  **119**    PRDAY13        Number of days from admission to PR13
  **120**    PRDAY14        Number of days from admission to PR14
  **121**    PRDAY15        Number of days from admission to PR15
  **122**    RACE           Race (uniform)
  **123**    TOTCHG         Total charges (cleaned)
  **124**    TOTCHG_X       Total charges (as received from source)
  **125**    YEAR           Calendar year
  **126**    ZIPInc_Qrtl    Median household income quartile for patient\'s ZIP Code

Complete list of 126 HCUP data elements. The elements marked with \"\*\" (rows 33-47) are the ones used in the classification as input variables.

\*HCUP data elements used in the classification

In addition, every record contains a vector of 15 diagnosis category codes. The diagnosis categories are computed using the Clinical Classification Software (CCS) developed by HCUP in order to categorize the ICD-9 diagnosis and procedure codes. CCS collapsed these codes into a smaller number of clinically meaningful categories, called diagnosis categories. Every ICD-9 code has a corresponding diagnosis category and every category contains a set of ICD-9 codes. We denote each of the 259 disease categories by a value between 1 and 259. In Figure [1](#F1){ref-type="fig"} we show an example of disease category (\"Breast cancer\") and some of the ICD-9 codes included in it (174.0 -\"Malignant neoplasm of female breast\", 174.1-Malignant neoplasm of central portion of female breast\", 174.2-Malignant neoplasm of upper-inner quadrant of female breast\", 233.0-\"Carcinoma in situ of breast and genitourinary system\").

![**Disease codes and categories hierarchical relationship**. This is a snap shot of the hierarchical relationship between the diseases and disease categories. For instance, disease category 49 (diabetes) has a children that are represented in disease codes (ICD-9-CM).](1472-6947-11-51-1){#F1}

Demographics such as age, race and sex are also included in the data set. Figure [2](#F2){ref-type="fig"} shows the distribution of patients across age, race and sex.

![**Demographics of patients by age, race and sex for the HCUP data set**.](1472-6947-11-51-2){#F2}

The data set is highly imbalanced. The imbalance rate ranges across diseases from 0.01-29.1%. 222 diagnosis categories occurs in less than 5% of the patients and only 13 categories occur in more than 10% of the patients. In table [2](#T2){ref-type="table"} we show the top 10 most prevalent disease categories and in table [3](#T3){ref-type="table"} we show some of the rarest diseases present in the 2005 HCUP data set.

###### 

The 10 most prevalent diseases categories

  Disease Category                    Prevalence
  ----------------------------------- ------------
  Hypertension                        29.1%
  Coronary Atherosclerosis            27.65%
  Hyperlipidemia                      14.46%
  Dysrhythmia                         14.35%
  Other Circulatory Diseases          12.02%
  Diabetes mellitus no complication   12%
  Anemia                              11.93%

The top 10 most prevalent diseases among the 8 million samples; it shows the percentage of the samples having that disease.

###### 

Some of the most imbalanced diseases categories

  Disease Category                   Percent of Active class
  ---------------------------------- -------------------------
  Male Genital Disease               0.01%
  Testis Cancer                      0.046%
  Encephalitis                       0.059%
  Aneurysm                           0.74%
  Breast Cancer                      1.66%
  Peripheral Atherosclerosis         3.16%
  Diabetes Mellitus w/complication   4.7%

One limitation of the 2005 HCUP data set is the arbitrary order in which the ICD-9 codes and disease categories were listed. The codes were not listed in the chronological order according to the date they were diagnosed. Also, the data set does not provide anonymous patient identifier, which could be used to check if multiple records belong to the same patient or to determine the elapsed time between diagnoses.

Data Pre-processing
-------------------

The data set was provided in a large ASCII file containing the 7,995,048 records. The first step was to parse the data set, randomly select *N*records and extract a set of relevant features. Every record is a sequence of characters that are not delimited. However, the data set instructions specifies the starting column and the ending column in the ASCII file for each data element (length of data element). HCUP provides a SAS program to parse the data set, but we chose to develop our own program to perform the parsing.

Feature Selection
-----------------

For every record, we extracted the age, race, sex and 15 diagnosis categories. Every record is represented as a *d*= 262 dimensional feature vector. Features 1-259 are binary, one for each disease category. The remaining three features are age, race and sex. We denote the samples that contain a given disease category as \"active\" and the remaining ones as \"inactive\". The active and inactive data samples are defined only from the point of view of the disease being classified. A snippet of the data set is presented in table [4](#T4){ref-type="table"}. For example, in table [4](#T4){ref-type="table"}, sample 1 is active for disease category 50, while sample *N*is inactive.

###### 

Sample Dataset, the bolded column (Cat. 50) represents the category to predict

  -------------------------------------------------------------------------------------------------------------------------------------
                    **Cat**.\   **Cat**.\   **Cat**.\   \....   **Cat**.\   \....   Cat. 257   Cat. 258   Cat. 259   Age   Race   Sex
                    1           2           3                   50                                                                
  ----------------- ----------- ----------- ----------- ------- ----------- ------- ---------- ---------- ---------- ----- ------ -----
  **Patient 1**     0           0           0           \....   **1**       \....   0          1          1          69    3      0

  .\                .\          .\          .\          .\      .\          .\      .\         .\         .\         .\    .\     .\
  .                 .           .           .           .       .           .       .          .          .          .     .      .

  **Patient *N***   1           0           0           \....   **0**       \....   1          0          0          55    1      1
  -------------------------------------------------------------------------------------------------------------------------------------

While, in general, using only disease categories may not lead to a valid disease prediction, the approach presented in this paper needs to be seen in the larger context of our TigerPlace eldercare research \[[@B11]\]. By integrating large public data sets (such as the one used in this paper) with monitoring sensors and electronic health records (EHR) data, we can achieve the required prediction precision for an efficient delivery of tailored medical information.

Learning from Imbalanced Data
-----------------------------

A data set is class-imbalanced if one class contains significantly more samples than the other. For many disease categories, the unbalance rate ranges between 0.01-29.1% (that is, the percent of the data samples that belong to the active class). For example, (see table [3](#T3){ref-type="table"}) only 3.16% of the patients have Peripheral Atherosclerosis. In such cases, it is challenging to create an appropriate testing and training data sets, given that most classifiers are built with the assumption that the test data is drawn from the same distribution as the training data \[[@B12]\].

Presenting imbalanced data to a classifier will produce undesirable results such as a much lower performance on the testing that on the training data. Among the classifier learning techniques that deal with imbalanced data we mention oversampling, undersampling, boosting, bagging and repeated random sub-sampling \[[@B13],[@B14]\]. In the next section we describe the repeated random sub-sampling method that we employ in this paper.

Repeated Random Sub-Sampling
----------------------------

Repeated random sub-sampling was found to be very effective in dealing with data sets that are highly imbalanced. Because most classification algorithms make the assumption that the class distribution in the data set is uniform, it is essential to pay attention to the class distribution when addressing medical data. This method divides the data set into active and inactive instances, from which the training and testing data sets are generated. The training data is partitioned into sub-samples with each sub-sample containing an equal number of instances from each class, except for last sub-sample (in some cases). The classification model is fitted repeatedly on every sub-sample and the final result is a majority voting over all the sub-samples.

In this paper we used the following repeated random sub-sampling approach. For every target disease we randomly choose *N*samples from the original HCUP data set. The *N*samples are divided into two separate data sets, *N~1~*active data samples and *N~0~*inactive data samples, where *N~1+~N~0\ =~N*. The testing data will contain 30% active samples *N~1~*(*TsN~1~*) while the remaining 70% will be sampled from the *N~0~*(*TsN~0~*) inactive samples. The 30/70 ratio was chosen by trial-and-error. The training data set will contain the remaining active samples (*TrN~1~*) and inactive samples (*TrN~0~*).

Since the training data is highly imbalanced (*TrN~1~*\>\>*TrN~0~*), the *TrN~0~*samples are partitioned into *NoS*training sub-samples, where *NoS*is the ratio between *TrN~0~*and *TrN~1~*. Every training sub-sample has equal number of instances of each class. The training active samples (*TrN~1~*) are fixed among all the training data sub-samples, while the inactive samples will be sampled without replacement from *TrN~0~*. There will be *NoS*sub-samples to train the model on. Eventually, every inactive sample in the training data is selected once, while every active sample is selected *NoS*times. After training the model on all the sub-samples, we employ a \"majority voting\" approach to determine the final class memberships (see Algorithm 1 in Additional File [1](#S1){ref-type="supplementary-material"}: Appendix). A diagram describing the process of RF and the sub-sampling procedure is presented in Figure [3](#F3){ref-type="fig"}.

![**Flow diagram of random forest and sub-sampling approach**.](1472-6947-11-51-3){#F3}

Random Forest
-------------

RF is an ensemble learner, a method that generates many classifiers and aggregates their results. RF will create multiple classification and regression (CART) trees, each trained on a bootstrap sample of the original training data and searches across a randomly selected subset of input variables to determine the split. CARTs are binary decision trees that are constructed by splitting the data in a node into child nodes repeatedly, starting with the root node that contains the whole learning sample \[[@B15]\]. Each tree in RF will cast a vote for some input *x*, then the output of the classifier is determined by majority voting of the trees (algorithm 2 in Additional File [1](#S1){ref-type="supplementary-material"}: Appendix). RF can handle high dimensional data and use a large number of trees in the ensemble. Some important features of RF are \[[@B16]\]:

1\. It has an effective method for estimating missing data.

2\. It has a method, weighted random forest (WRF), for balancing error in imbalanced data.

3\. It estimates the importance of variables used in the classification.

Chen et al. \[[@B17]\], compared WRF and balanced random forest (BRF) on six different and highly imbalanced data sets. In WRF, they tuned the weights for every data set, while in BRF, they changed the votes cutoff for the final prediction. They concluded that BRF is computationally more efficient than WRF for imbalanced data. They also found that WRF is more vulnerable to noise compared to BRF. In this paper, we used RF without tuning the class weights or the cutoff parameter.

Splitting Criterion
-------------------

Like CART, RF uses the Gini measure of impurity to select the split with the lowest impurity at every node \[[@B18]\]. Gini impurity is a measure of the class label distribution in the node. The Gini impurity takes values in \[0, 1\], where 0 is obtained when all elements in a node are of the same class. Formally, the Gini impurity measure for the variable *X*= {*x*~1~, *x*~2~, \..., *x*~j~} at node *t*, where *j*is the number of children at node *t*, *N*is the number of samples, *n~ci~*is the number of samples with value *x~i~*belonging to class *c*, *a~i~*is the number of samples with value *x~i~*at node *t*, then the Gini impurity is given by \[[@B15]\]

The Gini index of a split is the weighted average of the Gini measure over the different values of variable *X*, which is given by

The decision of the splitting criterion will be based on the lowest Gini impurity value computed among the *m*variables. In RF, each tree employs a different set of *m*variables to construct the splitting rules.

Variable Importance
-------------------

One of the most important features of RF is the output of the variable importance. Variable importance measures the degree of association between a given variable and the classification result. RF has four measures for the variable importance: raw importance score for class 0, raw importance score for class 1, decrease in accuracy and the Gini index. To estimate variable importance for some variable *j*, the out-of-bag (OOB) samples are passed down the tree and the prediction accuracy is recorded. Then the values for variable *j*are permuted in the OOB samples and the accuracy is measured again. These calculations are carried out tree by tree as the RF is constructed. The average decrease in accuracy of these permutations is then averaged over all the trees and is used to measure the importance of the variable *j*. If the prediction accuracy decreases substantially, then that suggests that the variable *j*has strong association with the response \[[@B19]\]. After measuring the importance of all the variables, RF will return a ranked list of the variable importance.

Formally, let *β~t~*be the OOB samples for tree *t*, *t*∈ {1,\..., *ntree*}, *y\'^t^~i~*is the predicted class for instance *i*before the permutation in tree *t*and *y\'^t^~i,α~*is the predicted class for instance *i*after the permutation. The variable importance *VI*for variable *j*in tree *t*is given by

The raw importance value for variable *j*is then averaged over all trees in the RF.

The variable importance used in this paper is the Mean Decrease Gini (MDG), which is based on the Gini splitting criterion discussed earlier. The MDG measure the decrease *ΔI*(equation 1) that results from the splitting. For two class problem, the change in *I*(equation 6) at node *t*is defined as the class impurity (equation 5) minus the weight average of Gini measure (equation 2) \[[@B20],[@B21]\].

The decrease in Gini impurity is recorded for all the nodes *t*in all the trees (*ntree*) in RF for all the variables and Gini Importance (*GI*) is then computed as \[[@B20]\].

Classification with Repeated Random Sub-Sampling
------------------------------------------------

Training the classifier on a data set that is small and highly imbalanced will result in unpredictable results as discussed in earlier sections. To overcome this issue, we used repeated random sub-sampling. Initially, we construct the testing data and the *NoS*training data sub-samples. For each disease, we train *NoS*classifiers and test all of them on the same data set. The final labels of the testing data are computed using a majority voting scheme.

Model Evaluation
----------------

To evaluate the performance of the RF we compared it to SVM on imbalanced data sets for eight different chronic diseases categories. Two sets of experiments were carried out:

Set I: We compared RF, boosting, bagging and SVM performance with repeated random sub-sampling. Both classifiers were fitted to the same training and testing data and the process was repeated 100 times. The ROC curve and the average AUC for each classifier were calculated and compared. To statistically compare the two ROC curves we employed an Analysis of Variance (ANOVA) approach \[[@B22]\] where the standard deviation of each AUC was computed as:

where *C~p~*, *C~n~*, θ are the number positive instances, negative instances and the AUC, respectively and

Set II: In this experiment we compare RF, bagging, boosting and SVM performance without the sampling approach. Without sampling the data set is highly imbalanced, while sampling should improve the accuracy since the training data sub-samples fitted to the model are balanced. The process was again repeated 100 times and the ROC curve and the average AUC were calculated and compared.

Results
=======

We performed the classification using R, which is open source statistical software. We used R Random Forest (randomForest), bagging (ipred), boosting (caTools) and SVM (e1071) packages. There are two parameters to choose when running a RF algorithm: the number of trees (*ntree*) and the number of randomly selected variables (*mtry*). The number of trees did not significantly influence the classification results. This can be seen in Figure [4](#F4){ref-type="fig"}, where we ran RF for different *ntree*values to predict breast cancer. As we see from Figure [4](#F4){ref-type="fig"}, the sensitivity of the classification did not significantly change once *ntree*\>20. The number of variables randomly sampled as candidates at each split (*mtry*) was chosen as the square root of the number of features (262 in our case), hence *mtry*was set to 16. Palmer et al. \[[@B23]\] and Liaw et al. \[[@B24]\] also reported that RF is usually insensitive to the training parameters.

![**RF behaviour when the number of trees (*ntree*) varies**. This plot shows how sensitivity in RF varies as the number of trees (*ntree*) varies, we varied *ntree*from 1-1001 in intervals of 25 and measured the sensitivity at every interval. Sensitivity ranged from 0.8457 when *ntree*= 1 and 0.8984 when *ntree*= 726. In our experiments we used *ntree*= 500 since the *ntree*did not have a large affect on accuracy for *ntree*\>1.](1472-6947-11-51-4){#F4}

For SVM we used a linear kernel, termination criterion (*tolerance*) was set to 0.001, *epsilon*for the insensitive-loss function was 0.1 and the regularization term (*cost*) was set to 1. Also, we left bagging and boosting with the default parameters.

We randomly selected *N*= 10,000 data points from the original HCUP data set. We predicted the disease risks on 8 out of the 259 disease categories. Those categories are: breast cancer, type 1 diabetes, type 2 diabetes, hypertension, coronary atherosclerosis, peripheral atherosclerosis, other circulatory diseases and osteoporosis.

Result set I: Comparison of RF, bagging, boosting and SVM
---------------------------------------------------------

RF, SVM, bagging and boosting classification were performed 100 times and the average area under the curve (AUC) was measured (ROC curves for the four classifiers for diabetes with complication, hypertension and breast cancer are shown in Figure [5](#F5){ref-type="fig"}, Figure [6](#F6){ref-type="fig"} and Figure [7](#F7){ref-type="fig"}, respectively). The repeated random sub-sampling approach has improved the detection rate considerably. On seven out of eight disease categories RF outperformed the other classifiers in terms of AUC (table [5](#T5){ref-type="table"}). In addition to ROC comparison, we used ANOVA \[[@B22]\] as mentioned earlier to statistically compare the ROC of boosting and RF, since both of these classifiers scored the highest in terms of AUC. ANOVA results comparing RF ROC and boosting ROC are summarized in table [6](#T6){ref-type="table"}. The lower the *p*value is the more significant the difference between the ROCs is. The results of ANOVA test tells us that although RF outperformed boosting in terms of AUC, that performance was only significant in three diseases only (high prevalence diseases). The possible reason for performance difference insignificance for the other 5 diseases (mostly low prevalence diseases) might be the low number of active samples available in our sampled dataset. For example, for breast cancer we would have about 166 cases available.

![**ROC curve for diabetes mellitus**. ROC curve for diabetes mellitus comparing SVM, RF, boosting and bagging.](1472-6947-11-51-5){#F5}

![**ROC curve for hypertension**. ROC curve for hypertension comparing both SVM, RF, boosting and bagging.](1472-6947-11-51-6){#F6}

![**ROC curve for breast cancer**. ROC curve for breast cancer comparing both SVM, RF, boosting and bagging.](1472-6947-11-51-7){#F7}

###### 

RF, SVM, bagging and boosting performance in terms of AUC on eight disease categories

  Disease                      RF            SVM      Bagging   Boosting
  ---------------------------- ------------- -------- --------- ----------
  Breast cancer                **0.9123**    0.9063   0.905     0.8886
  Diabetes no complication     **0.8791**    0.8417   0.8568    0.8607
  Diabetes with/complication   **0.94317**   0.9239   0.9294    0.9327
  Hypertension                 **0.9003**    0.8592   0.8719    0.8842
  Coronary Atherosclerosis     **0.9199**    0.8973   0.887     0.9026
  Peripheral Atherosclerosis   **0.9095**    0.8972   0.8967    0.9003
  Other Circulatory Diseases   **0.7899**    0.7591   0.7669    0.7683
  Osteoporosis                 **0.87**      0.867    0.8659    0.8635

###### 

Statistical comparison of RF and boosting ROC curves, the lower the value the more significant the difference is

  Disease                      *p*value
  ---------------------------- ----------
  Breast cancer                0.8057
  Diabetes no complication     0.3293
  Diabetes with/complication   0.6266
  Hypertension                 0.2
  Coronary Atherosclerosis     0.2764
  Peripheral Atherosclerosis   0.8203
  Other Circulatory Diseases   0.566
  Osteoporosis                 0.908

We compared our disease prediction results to the ones reported by other authors. For instance, Yu et al. \[[@B1]\], describes a method using SVM for detecting persons with diabetes and pre-diabetes. They used data set from the National Health and Nutrition Examination Survey (NHANES). NHANES collects demographic, health history, behavioural information and it may also include detailed physical, physiological, and laboratory examinations for each patient. The AUC for their classification scheme I and II was 83.47% and 73.81% respectively. We also predicted diabetes with complications and without complications and the AUC values were 94.31% and 87.91% respectively (Diabetes without complication ROC curve in Figure [5](#F5){ref-type="fig"}).

Davis et al. \[[@B8]\] used clustering and collaborative filtering to predict disease risks of patients based on their medical history. Their algorithm generates a ranked list of diseases in the subsequent visits of that patient. They used an HCUP data set, similar to the data set we used. Their system predicts more than 41% of all the future diseases in the top 20 ranks. One reason for their low system performance might be that they tried to predict the exact ICD-9 code for each patient, while we predict the disease category.

Zhang et al. \[[@B10]\] performed classification on breast cancer metastasis. In their study, they used two published gene expression profiles. They compared multiple methods (logistic regression, SVM, AdaBoost, LogitBoost and RF). In the first data set, the AUC for SVM and RF was 88.6% and 89.9% respectively and for the second data set 87.4% and 93.2%. The results we obtained for breast cancer prediction for RF were 91.23% (ROC curve in Figure [7](#F7){ref-type="fig"}).

Mantzaris et al \[[@B9]\] predicted osteoporosis using multi-layer perceptron (MLP) and probabilistic neural network (PNN). Age, sex, height and weight were the input variables to the classifier. They reported a prognosis rate on the testing data of 84.9%. One the same disease, we reported an AUC for RF of 87%.

One of the important features of the RF approach is the computation of the importance of each variable (feature). We used Mean Decrease Gini (Equations 5, 6, 7) measure to achieve the variable importance (table [7](#T7){ref-type="table"}). Variables with high importance have strong association with the prediction results. For example, Mantzaris et al. \[[@B9]\] mentioned that osteoporosis (row 8) is more prevalent in people older than 50 and occurs in women more than men and that agrees with the first and forth important variables (age and sex) reported by RF (Table [7](#T7){ref-type="table"}). Another example is diabetes with complication (row 3) that often presents with fluid-electrolyte imbalance and it\'s incidence is inversely correlated with a normal pregnancy.

###### 

Top four most importance variable for the eight disease categories

  ---------------------------------------------------------------------------------------------------------------------------------
  Disease                          Variable 1   Variable 2        Variable 3
  -------------------------------- ------------ ----------------- -----------------------------------------------------------------
  1\. Breast cancer                Age          Sex               Secondary malignant Secondary malignant sddsmalignant malignant

  2\. Diabetes no complication     Age          Hypertension      Hyperlipidemia

  3\. Diabetes with/complication   Age          Normal\           Fluid-electrolyte\
                                                pregnancy         imbalance

  4\. Hypertension                 Age          Hyperlipidemia    Diabetes without compl.

  5\. Coronary atherosclerosis     Age          Hypertension      Hyperlipidemia

  6\. Peripheral atherosclerosis   Age          Coronary\         Hypertension
                                                Atherosclerosis   

  7\. Other circulatory diseases   Age          Dysthymia         Anemia

  8\. Osteoporosis                 Age          Race              Hypertension
  ---------------------------------------------------------------------------------------------------------------------------------

Result set II: Sampling vs. non-sampling
----------------------------------------

In this section we show that classification with sampling outperforms standalone classifiers on the HCUP data set (table [8](#T8){ref-type="table"}). RF, bagging, boosting and SVM with sampling have higher ROC curves and reaches a detection rate of 100% faster than the standalone classifiers. For demonstration purposes, we included the comparisons for RF with and without sampling for three disease categories, breast cancer, other circulatory diseases and peripheral atherosclerosis (ROC curve in Figure [8](#F8){ref-type="fig"}, Figure [9](#F9){ref-type="fig"}, and Figure [10](#F10){ref-type="fig"}). Table [8](#T8){ref-type="table"} describes the results for the non-sampling classification for the four mentioned classifiers.

###### 

RF, SVM, bagging and boostingperformance without sub-sampling in terms of AUC on eight disease categories

  Disease                      RF           SVMSVM   Bagging   Boosting
  ---------------------------- ------------ -------- --------- ------------
  Breast cancer                **0.8793**   0.5      0.5085    0.836
  Diabetes no complication     **0.8567**   0.5      0.4749    0.8175
  Diabetes with/complication   **0.9084**   0.648    0.4985    0.8278
  Hypertension                 **0.8893**   0.6908   0.4886    0.8515
  Coronary Atherosclerosis     **0.9193**   0.6601   0.4945    0.8608
  Peripheral Atherosclerosis   **0.8872**   0.5      0.4925    0.8279
  Other Circulatory Diseases   **0.7389**   0.5      0.4829    0.6851
  Osteoporosis                 0.7968       0.5      0.4931    **0.8561**

![**ROC curve for breast cancer (sampling vs. non-sampling)**. ROC curve for breast cancer comparing RF with the sampling and non-sampling approach.](1472-6947-11-51-8){#F8}

![**ROC curve for other circulatory diseases (sampling vs. non-sampling)**. ROC curve for other circulatory diseases comparing RF with the sampling and non-sampling approach.](1472-6947-11-51-9){#F9}

![**ROC curve for peripheral atherosclerosis (sampling vs. non-sampling)**. ROC curve for peripheral atherosclerosis comparing RF with the sampling and non-sampling approach.](1472-6947-11-51-10){#F10}

Discussion
==========

Disease prediction is becoming an increasingly important research area due to the large medical datasets that are slowly becoming available. While full featured clinical records are hard to access due to privacy issues, deidentified large public dataset are still a valuable resource for at least two reasons. First, they may provide population level clinical knowledge. Second, they allow the data mining researcher to develop methodologies for clinical decision support systems that can then be employed for electronic medical records. In this study, we presented a disease prediction methodology that employs random forests (RF) and a nation-wide deidentified public dataset (HCUP). We show that, since no national medical warehouse is available to date, using nation-wide datasets provide a powerful prediction tool. In addition, we believe that the presented methodology can be employed with electronic medical records, if available.

To test our approach we selected eight chronic diseases with high prevalence in elderly. We performed two sets of experiments (set I and set II). In set I, we compared RF to other classifiers with sampling, while in set II we compared RF to other classifiers without sub-sampling. Our results show that we can predict diseases with an acceptable accuracy using the HCUP data. In addition, the use of repeated random sub-sampling is useful when dealing with highly imbalanced data. We also found that incorporating demographic information increased the area under the curve by 0.33-10.1%.

Some of the limitations of our approach come from limitations of the HCUP data set such as the arbitrary order of the ICD-9 codes and lack of patient identification. For example, since the ICD-9 codes are not listed in chronological order according to the date they were diagnosed, we inherently use future diseases in our prediction. This explains, in part, the high accuracy of our prediction. In addition, the HCUP data set does not provide anonymous patient identifier, which can be used to check if multiple records belong to the same patient and to estimate the time interval between two diagnoses. Hence we might use the data for the same patient multiple times.

Additionally, the data set does not include the family history; rather it includes the individual diagnosis history which is represented by the diseases categories.

Conclusions
===========

In this study we used the NIS dataset (HCUP) created by AHRQ. Few researchers have utilized the NIS dataset for disease predictions. The only work we found on disease prediction using NIS data was presented by Davis et al. \[[@B5]\], in which clustering and collaborative filtering was used to predict individual disease risks based on medical history. In this work we provided extensive proof that RF can be successfully used for disease prediction in conjunction with the HCUP dataset.

The accuracy achieved in disease prediction is comparable or better than the previously published results. The average RF AUC obtained across all disease was about 89.05% which may be acceptable in many applications. Additionally, unlike many other published results were they focus on predicting one specific disease, our method can be used to predict the risk for any disease. Finally, we consider the results obtained with the proposed method adequate for our intended use, which is tailored health communication.
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